(HealthDay News) — A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer. A phase 3 clinical trial has shown that circulating tumor cell (CTC) counts can predict which men are likely to respond to standard treatment and live longest and which might benefit from more […]
